Table 2 Eligibility criteria for patient participation in the Rhode Island collaborative practice agreement for naloxone (CPAN)
From: Orienting patients to greater opioid safety: models of community pharmacy-based naloxone
▪ Voluntarily request |
▪ Recipient of emergency medical care for acute opioid poisoning |
▪ Suspected illicit or nonmedical opioid user |
▪ High dose opioid prescription (>100 morphine mg equivalents daily) |
▪ Methadone prescription to opioid naïve patient |
▪ Dispensed an opioid prescription and: |
▪ History of smoking |
▪ COPD |
▪ Respiratory illness or obstruction |
▪ Renal dysfunction or hepatic disease |
▪ Known or suspected concurrent alcohol abuse |
▪ Concurrent benzodiazepine prescription |
▪ Concurrent SSRI or TCA anti-depressant prescription |
▪ Recently released prisoners from a correctional facility |
▪ Released from opioid detoxification or mandatory abstinence program |
▪ Patients entering a methadone maintenance treatment program |
▪ Patients that may have difficulty accessing emergency medical services |